According to Viridian Capital Advisors, $1.23 billion dollars in registered investments were made into cannabis and industrial hemp companies in the first few weeks of the year, up 600% from 2016.
75% of the capital raises flowed towards public companies like: Hydropothecary Corp (OTC: HYYDF) $121.1 million, MedReleaf Corp (TSX: LEAF)$107.6 million, Organigram Holdings Inc (TSXV: OGI) $93.4 million, Aphria Inc (TSX: APH)$91.9 million.
With 9 of the more than 65 capital raises reaching over $50 million dollars, it’s clear that 2018 will become one of the most profitable years to date for investors in the sector.
A recent report by the BrightField Group, estimated that the international cannabis market will become worth $31.4 billion by 2021. Companies and investors in the sector can plan to see a compound annual growth rate of 60%.
Canada plans to become one of the worlds largest exporters of cannabis and hemp derived goods. Germany, the Czech Republic, Australis and New Zealand headline a list of countries looking to the Canada for legally grown high quality cannabis and hemp derived products. By March 2017 they had sent 528 kilograms of dried
cannabis flower and 911 litres of oil overseas.